Find Federal Grants
U.S. Mission to France · PDS-FRANCE-FY2022-03
National Institutes of Health · RFA-HL-23-006
Emergency Awards: HEAL Initiative-Limited Competition: HEAL Initiative Resource Centers for the Pain Management Effectiveness Research Network (ERN) (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-TR-22-012
Health Resources and Services Administration · HRSA-22-066
Nonhuman Primate Transplantation Tolerance Cooperative Study Group (U19 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-22-003
Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed)
National Institutes of Health · RFA-MH-22-111
Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-MH-22-110
Nonhuman Primate Transplantation Tolerance Cooperative Study Group (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-22-002
Health Resources and Services Administration · HRSA-22-061
Supporting the Implementation of Sustainable, Comprehensive, High Quality HIV Prevention and Treatment Programs in the Central Region of the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH22-2211
Health Resources and Services Administration · HRSA-22-054
Mozambique USAID-Maputo · 72065622RFA00004
Centers for Disease Control - OPHPR · CDC-RFA-TP22-2201
In Vitro Based Approaches to Evaluate the Bioequivalence of Generic Rectal and Vaginal Products
Food and Drug Administration · RFA-FD-22-014
Mozambique USAID-Maputo · 72065622RFA00003
Rigorous Evaluation of Community-Centered Approaches for the Prevention of Community Violence
Centers for Disease Control and Prevention - ERA · RFA-CE-22-013
The CDC National Centers of Excellence in Youth Violence Prevention (YVPCs): Rigorous Evaluation of Prevention Strategies to Prevent and Reduce Community Rates of Youth Violence
Centers for Disease Control and Prevention - ERA · RFA-CE-22-012
Physiologically Based Pharmacokinetic Model for Nose-to-Brain Drug Delivery (U01) Clinical Trial Optional
Food and Drug Administration · RFA-FD-22-016
Development of advanced analytical methods for the characterization of complex generics
Food and Drug Administration · RFA-FD-22-013
PBPK modeling to support assessment of bioequivalence of locally acting drugs in the gastrointestinal tract
Food and Drug Administration · RFA-FD-22-012